NASDAQ:AKRO
Akero Therapeutics, Inc.
- Stock
Last Close
28.32
26/07 20:00
Market Cap
1.66B
Beta: −0.94
Volume Today
412.32K
Avg: 611.93K
PE Ratio
−9.80
PFCF: −9.21
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||
average payables | 716.50K - | 1.16M 61.90% | 2.19M 88.58% | 5.07M 131.63% | 7.34M 44.80% | 7.50M 2.26% | ||
average receivables | ||||||||
book value per share | -2.35 - | 8.54 463.16% | 8.22 3.73% | 4.86 40.95% | 8.38 72.51% | 10.18 21.57% | ||
capex per share | -0.24 - | -0.00 - | ||||||
capex to depreciation | -8.71 - | |||||||
capex to operating cash flow | 1.08 - | 0.00 - | ||||||
capex to revenue | ||||||||
cash per share | 3.58 - | 13.80 285.58% | 8.53 38.20% | 5.41 36.63% | 9.02 66.78% | 10.46 16.06% | ||
days of inventory on hand | ||||||||
days payables outstanding | 88.58K - | |||||||
days sales outstanding | ||||||||
debt to assets | 0.01 - | 0.01 17.08% | 0.03 295.94% | 0.04 41.62% | ||||
debt to equity | 0.01 - | 0.01 28.14% | 0.03 273.87% | 0.05 40.59% | ||||
dividend yield | 0.19 - | |||||||
earnings yield | -0.21 - | -0.13 37.77% | -0.10 25.41% | -0.14 40.19% | -0.05 62.72% | -0.12 142.52% | ||
enterprise value | -598K - | 312.85M 52,416.47% | 198.17M 36.66% | 626.32M 216.05% | 587.63M 6.18% | 1.90B 222.91% | 1.02B 46.28% | |
enterprise value over ebitda | -3.83 - | -4.34 13.38% | -7.81 80.00% | -5.82 25.46% | -17.05 192.71% | -5.90 65.41% | ||
ev to operating cash flow | -67.64 - | -5.56 91.78% | -8.85 59.03% | -7.37 16.63% | -20.51 178.11% | -7.01 65.81% | ||
ev to sales | ||||||||
free cash flow per share | -0.45 - | -2.36 421.29% | -2.26 4.61% | -2.29 1.45% | -2.37 3.73% | -2.77 16.52% | ||
free cash flow yield | -0.02 - | -0.11 330.18% | -0.09 17.92% | -0.11 23.76% | -0.04 59.97% | -0.12 173.47% | ||
graham net net | -2.41 - | 13.18 647.45% | 8.07 38.80% | 4.65 42.39% | 8.25 77.46% | 9.61 16.52% | ||
graham number | 14.27 - | 23.62 65.49% | 21.58 8.65% | 17.78 17.62% | 22.95 29.08% | 25.72 12.08% | ||
income quality | 0.06 - | 0.81 1,338.59% | 0.89 9.78% | 0.79 11.55% | 0.83 4.44% | 0.96 15.99% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -155.83 - | -55.78 64.20% | ||||||
interest debt per share | 0.06 - | 0.04 24.33% | 0.30 588.52% | 0.54 79.77% | ||||
inventory turnover | ||||||||
invested capital | 0.01 - | 0.01 28.14% | 0.03 273.87% | 0.05 40.59% | ||||
market cap | 388.83M - | 334.57M 13.95% | 811.75M 142.63% | 736.60M 9.26% | 2.14B 190.03% | 1.23B 42.54% | ||
net current asset value | -4.58M - | -49.94M 989.42% | 128.66M 357.63% | 256.72M 99.54% | 167.14M 34.89% | 325.17M 94.54% | 515.00M 58.38% | |
net debt to ebitda | 0.93 - | 2.99 221.36% | 2.31 22.57% | 1.48 36.17% | 2.15 45.33% | 1.20 43.88% | ||
net income per share | -3.85 - | -2.90 24.59% | -2.52 13.31% | -2.89 14.92% | -2.79 3.42% | -2.89 3.34% | ||
operating cash flow per share | -0.22 - | -2.36 984.84% | -2.25 4.81% | -2.29 1.67% | -2.37 3.73% | -2.77 16.52% | ||
payables turnover | 0.00 - | |||||||
receivables turnover | ||||||||
research and ddevelopement to revenue | ||||||||
return on tangible assets | -1.06 - | -0.32 70.09% | -0.29 8.55% | -0.52 77.81% | -0.31 40.71% | -0.26 14.37% | ||
revenue per share | ||||||||
roe | 1.64 - | -0.34 120.76% | -0.31 9.95% | -0.60 94.61% | -0.33 44.01% | -0.28 14.99% | ||
roic | 0.28 - | -0.35 228.49% | -0.31 13.86% | -0.59 91.77% | -0.33 43.62% | -0.31 6.77% | ||
sales general and administrative to revenue | ||||||||
shareholders equity per share | -2.35 - | 8.54 463.16% | 8.22 3.73% | 4.86 40.95% | 8.38 72.51% | 10.18 21.57% | ||
stock based compensation to revenue | ||||||||
tangible asset value | -4.56M - | -49.92M 993.76% | 128.73M 357.87% | 258.71M 100.98% | 169.11M 34.63% | 326.56M 93.11% | 535.31M 63.92% | |
tangible book value per share | -2.35 - | 8.54 463.16% | 8.22 3.73% | 4.86 40.95% | 8.38 72.51% | 10.18 21.57% | ||
working capital | 416K - | 74.79M 17,878.13% | 128.68M 72.06% | 258.23M 100.68% | 168.45M 34.77% | 336.09M 99.51% | 540.83M 60.92% |
All numbers in USD (except ratios and percentages)